226 related articles for article (PubMed ID: 1372051)
1. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
[TBL] [Abstract][Full Text] [Related]
2. Modification of exercise-aggravated coxsackievirus B3 murine myocarditis by T lymphocyte suppression in an inbred model.
Cabinian AE; Kiel RJ; Smith F; Ho KL; Khatib R; Reyes MP
J Lab Clin Med; 1990 Apr; 115(4):454-62. PubMed ID: 2157783
[TBL] [Abstract][Full Text] [Related]
3. Effects of naloxone, an opiate receptor antagonist, on coxsackievirus B3 myocarditis in the mouse.
Kishimoto C; Takada H; Hiraoka Y; Shiraki K
Cardiovasc Res; 1995 Jan; 29(1):80-4. PubMed ID: 7895243
[TBL] [Abstract][Full Text] [Related]
4. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
5. Role of MIP-2 in coxsackievirus B3 myocarditis.
Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H
J Mol Cell Cardiol; 2000 Apr; 32(4):631-8. PubMed ID: 10756119
[TBL] [Abstract][Full Text] [Related]
6. The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
Takada H; Kishimoto C; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Heart Vessels; 1993; 8(2):59-66. PubMed ID: 8390975
[TBL] [Abstract][Full Text] [Related]
7. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
Khatib R; Reyes MP; Khatib G; Giraldo A
Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
Glück B; Dahlke K; Zell R; Krumbholz A; Decker M; Lehmann J; Wutzler P
J Med Virol; 2010 Dec; 82(12):2043-52. PubMed ID: 20981792
[TBL] [Abstract][Full Text] [Related]
9. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis.
Kishimoto C; Thorp KA; Abelmann WH
Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299
[TBL] [Abstract][Full Text] [Related]
11. Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model.
Rezkalla S; Khatib R; Khatib G; Smith F; Walsh M; Sowers J; Kloner R
J Lab Clin Med; 1988 Jul; 112(1):118-21. PubMed ID: 2839587
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular cell adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.
Seko Y; Yagita H; Okumura K; Yazaki Y
J Pathol; 1996 Dec; 180(4):450-4. PubMed ID: 9014868
[TBL] [Abstract][Full Text] [Related]
13. Absence of effects of cyclosporine on myocardial lymphocyte subsets in Coxsackievirus B3 myocarditis in the aviremic stage.
Kishimoto C; Abelmann WH
Circ Res; 1989 Oct; 65(4):934-45. PubMed ID: 2551533
[TBL] [Abstract][Full Text] [Related]
14. Effect of verapamil on acute coxsackievirus B3 murine myocarditis.
Xu Y; Yang YZ; Chen HZ; Jin PY; Guo Q; Zhao WZ; Yang JH; Cai QX; Zhou YC
Chin Med J (Engl); 1992 Oct; 105(10):818-21. PubMed ID: 1337875
[TBL] [Abstract][Full Text] [Related]
15. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
Kishimoto C; Takada H; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Cardiovasc Res; 1993 Feb; 27(2):243-8. PubMed ID: 8386064
[TBL] [Abstract][Full Text] [Related]
17. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice.
Hiraoka Y; Kishimoto C; Takada H; Suzaki N; Shiraki K
Eur Heart J; 1995 Dec; 16(12):1900-6. PubMed ID: 8682024
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Chinese herbal medicine Xin-kang oral liquid on interferon-induction and its antiviral activity in coxsackievirus B3 infected mice].
Wan SJ; Li JN; Zhao H; Wang LX; Huang XZ; Zhu Y; Chen HS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):77-9. PubMed ID: 16201482
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.
Kanda T; Nagaoka H; Kaneko K; Wilson JE; McManus BM; Imai S; Suzuki T; Murata K; Kobayashi I
J Pharmacol Exp Ther; 1995 Jul; 274(1):487-93. PubMed ID: 7542339
[TBL] [Abstract][Full Text] [Related]
20. Anti-perforin neutralizing antibody reduces myocardial injury in viral myocarditis.
Chun-yan G; Bo H; Hong C; Hong-lei J; Xiu-zhen H
Cardiol Young; 2009 Dec; 19(6):601-7. PubMed ID: 19825252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
